retatrutide clinical trial information stage Retatrutide Results After 40: Realistic Timelines & FAQ Retatrutide, an investigational triple hormone

John Burns Dallas Introduction If you follow weight loss medicine, you have probably already heard the buzz around retatrutide a next-generation GLP-1 triple agonist that has produced weight loss results in clinical trials that surpass even semaglutide and tirzepatide

A 2021 study found that individuals on a higher dose of GLP-1 lost an average of 15% (34 lbs) weight loss, with 44% of that weight loss (15 lbs) coming from muscle (Wilding et al, 2021)

Legumes: Lentils, chickpeas, and black beans (the ultimate GLP-1 powerhouse foods)

The triple-hormone mechanism (GLP-1, GIP, and glucagon) means it has a stronger effect on your appetite and digestive system than single or dual-hormone treatments like Wegovy or Mounjaro

And physicians find theres still food in their stomachs. Thiara also says the risks of taking GLP-1 medication during pregnancy havent received nearly enough attention, given that the majority of patients on the drugs are women

Leading digital weight management solution providers already started to offer companion solutions for GLP-1 patients